- Moody's•1 hour ago
New York, February 24, 2017-- Moody's Investors Service assigned an A1 rating to new senior unsecured notes being offered by Pfizer Inc.. The rating outlook is stable. There are no changes to Pfizer's ...
- Zacks•3 hours ago
Cancer drugs developed by Pfizer (PFE) and Novartis got priority review while Bristol-Myers is being considered the next acquisition target.
- GuruFocus.com•16 hours ago
Stocks mixed with gains led by Johnson & Johnson and Pfizer
PFE : Summary for Pfizer, Inc. - Yahoo Finance
Pfizer Inc. (PFE)
NYSE - NYSE Real Time Price. Currency in USD
Add to watchlist
|Day's Range||33.99 - 34.35|
|52 Week Range||28.74 - 37.39|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||29.18|
|Dividend & Yield||1.28 (3.81%)|
|1y Target Est||N/A|